| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $121,948,946 ) (Continued on the next page) |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R03AI180319 | Enzymology and Structure of Divergent Type 4 Pilus Extension ATPases | 000 | 1 | NIH | 1/12/2024 | $69,863 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UH3DA050311 | Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder | 003 | 4 | NIH | 4/24/2024 | $144,562 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UH3DA050311 | Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder | 002 | 4 | NIH | 2/1/2024 | $1,301,065 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UH3DA050311 | Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder | 002 | 4 | NIH | 2/1/2024 | -$1,301,065 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UH3DA050311 | Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder | 001 | 4 | NIH | 1/4/2024 | $1,301,065 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK107451 | The role of AEG-1 in NASH and NASH-HCC | 002 | 7 | NIH | 5/15/2024 | $36,092 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK107451 | The role of AEG-1 in NASH and NASH-HCC | 000 | 7 | NIH | 12/12/2023 | $541,369 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK107451 | The role of AEG-1 in NASH and NASH-HCC | 001 | 7 | NIH | 12/15/2023 | $70,363 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA244993 | Novel Targeted Combinatorial Therapy for Hepatocellular Carcinoma | 003 | 5 | NIH | 6/27/2024 | $0 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA244993 | Novel Targeted Combinatorial Therapy for Hepatocellular Carcinoma | 002 | 5 | NIH | 4/22/2024 | $25,227 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA244993 | Novel Targeted Combinatorial Therapy for Hepatocellular Carcinoma | 001 | 5 | NIH | 1/25/2024 | $61,505 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA244993 | Novel Targeted Combinatorial Therapy for Hepatocellular Carcinoma | 000 | 5 | NIH | 1/22/2024 | $367,494 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA056876 | Long-term microglia-targeted endogenous retrovirus-like particle (ERVLP) delivery of Cas12f editor to cure HIV | 002 | 4 | NIH | 7/3/2024 | $576,854 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CE003625 | RFA-CE-23-006, A Virtual Reality Brief Violence Intervention: Preventing gun violence among violently injured adults | 00 | 2 | CDC | 6/14/2024 | $649,818 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK135815 | Modeling genetic contributions to biliary atresia | 001 | 2 | NIH | 8/20/2024 | $601,309 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01MH129356 | Harnessing advances in the genetics of suicidality to identify and dissect psychosocial pathways to risk | 001 | 3 | NIH | 7/5/2024 | $54,770 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R03TR004254 | UNderstanding the Delivery of Low-Value CAre To CHildren and the Barriers to De-Implementation (UN-LATCH) | 000 | 2 | NIH | 6/18/2024 | $77,625 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UK146072 | Nurse Education, Practice, Quality and Retention | 00 | 3 | HRSA | 7/1/2024 | $941,975 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01NS130103 | Experimental Studies of Endoscopic Third Ventriculostomy and Choroid Plexus Cauterization in Hydrocephalus | 001 | 3 | NIH | 9/9/2024 | $587,728 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K12TR004364 | CTSA K12 Program at Virginia Commonwealth University | 001 | 2 | NIH | 9/10/2024 | $0 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01MH129356 | Harnessing advances in the genetics of suicidality to identify and dissect psychosocial pathways to risk | 000 | 3 | NIH | 12/15/2023 | $492,920 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA030005 | Genetic, Social, and Developmental Epidemiology of Drug Use Disorders | 000 | 14 | NIH | 1/11/2024 | $530,827 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AA029398 | Fecal microbiota transplant for Alcohol-Associated Cirrhosis | 000 | 3 | NIH | 7/29/2024 | $591,596 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K12TR004364 | CTSA K12 Program at Virginia Commonwealth University | 000 | 2 | NIH | 5/21/2024 | $749,462 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R34MH129464 | Neuroscience-informed treatment to remotely target reward mechanisms in post-acute anorexia nervosa | 000 | 3 | NIH | 7/2/2024 | $214,380 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA058089 | Reprogramming KZFP function to understand drug-specific transcription and behavior | 000 | 1 | NIH | 4/24/2024 | $515,586 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32MH020030 | ResearchTraining: Psychiatric and Statistical Genetics. | 000 | 25 | NIH | 6/21/2024 | $301,636 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | P01CA275740 | ExpLoiting thErapeutic VulnerAbilities in hepaTocEllular carcinoma (ELEVATE) | 000 | 1 | NIH | 8/1/2024 | $2,678,459 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R03DE034047 | Immigration vulnerability and oral health among Latinx/a/o people | 000 | 1 | NIH | 9/10/2024 | $161,981 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | E3621728 | LDS - Allopathic Medicine | 000 | 4 | HRSA | 6/27/2024 | $21,761 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U1Q53069 | Geriatrics Workforce Enhancement Program | 01 | 1 | HRSA | 9/10/2024 | $1,742 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U1Q53069 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 5/23/2024 | $368,914 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U1Q53069 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 5/23/2024 | $631,086 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U7A50521 | State Maternal Health Innovation Program | 00 | 2 | HRSA | 9/9/2024 | $1,500,000 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | 90RTEM0014 | RRTC on Employment Among Transition-Age Youth with Disabilities 2024 | 00 | 1 | ACL | 8/20/2024 | $875,000 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | P1053116 | Rural Health Network Development Planning Grant Program | 00 | 1 | HRSA | 5/22/2024 | $99,327 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T2537629 | Addiction Medicine Fellowship | 01 | 5 | HRSA | 7/23/2024 | $24,612 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T2537629 | Addiction Medicine Fellowship | 00 | 5 | HRSA | 5/16/2024 | $650,280 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | D4033378 | Graduate Psychology Education Programs | 01 | 6 | HRSA | 8/16/2024 | $3,805 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | D4033378 | Graduate Psychology Education Programs | 01 | 6 | HRSA | 8/16/2024 | $11,413 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | D4033378 | Graduate Psychology Education Programs | 00 | 6 | HRSA | 6/5/2024 | $112,500 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | D4033378 | Graduate Psychology Education Programs | 00 | 6 | HRSA | 6/5/2024 | $337,500 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | 90RTEM0013 | RRTC on Employment Among People with Intellectual and Developmental Disabilities 2024 | 00 | 1 | ACL | 8/20/2024 | $875,000 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F99CA294259 | An In-depth Examination of Psychological Distress among Black Breast Cancer Survivors | 000 | 1 | NIH | 8/21/2024 | $50,474 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R56DE028919 | Role of Wnt Signaling in Macrophage Response to Biomaterials | 000 | 6 | NIH | 8/15/2024 | $361,785 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA285692 | MYCN drives a druggable SUMOylation program in neuroblastoma | 000 | 1 | NIH | 12/27/2023 | $434,312 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R34DA061267 | Neurocognitive, genetic and socioenvironmental influences on a developmental precursors to addiction: A cross-species study | 000 | 1 | NIH | 8/14/2024 | $346,911 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U24DK138889 | VCU National Coordinating Center for Advancing Gender Inclusive Excellence | 000 | 1 | NIH | 8/27/2024 | $100,000 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U24DK138889 | VCU National Coordinating Center for Advancing Gender Inclusive Excellence | 000 | 1 | NIH | 8/27/2024 | $421,354 |
|